Two more Russian vaccines: What we do and don't know Russia has approved three coronavirus vaccines — first, Sputnik-V, then EpiVacCorona and CoviVac. But clinical trials for the last two are incomplete. Russia wants to produce 50 million vaccine sets by May Russia wants the majority of its citizens to be vaccinated against the novel coronavirus, SARS-CoV-2, by the autumn of 2021. And it appears to be pushing three homegrown vaccines to meet that goal at all costs. All three of those vaccines have been approved prior to completing large-scale phase 3 clinical trials — an internationally recognized scientific standard that aims to ensure the safety and efficacy of vaccines.